Table 1 Prevalence of delirium symptoms evaluated by the ICDSC at study baseline
Delirium symptons derived from ICSDC | Quetiapine (n= 14) N (%) | Placebo (n= 15) N (%) | P-value |
|---|---|---|---|
Agitation | 5 (35.7) | 6 (40.0) | 0.81 |
Decreased level of consciousness | 6 (42.9) | 6 (40.0) | 0.88 |
Inattention | 13 (92.9) | 15 (100.0) | 0.29 |
Disorientation | 13 (92.9) | 11 (84.6) | 0.49 |
Hallucinations/Delusions | 2 (14.3) | 1 (6.7) | 1.00 |
Hyperactivity | 5 (35.7) | 6 (40.0) | 0.81 |
Hypoactivity | 9 (64.3) | 9 (60.0) | 0.81 |
Inappropriate speech or mood | 7 (77.8) | 3 (42.9) | 0.15 |
Sleep/wake cycle disturbances | 8 (66.7) | 10 (71.4) | 0.79 |
Symptom fluctuation | 11 (91.7) | 13 (86.7) | 0.68 |